Should You Buy Permian Basin Royalty Trust Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Permian Basin Royalty Trust (PBT) scores 5.1/10 on our Quality of Company framework, indicating mixed operational fundamentals. At the current price of $36.11, our multi-model valuation analyzes whether the market has already discounted these weaknesses.
The short answer: 0 of 2 CirclFi valuation models project upside for Permian Basin Royalty Trust (PBT) at $36.11 — the model consensus leans bearish, with a Quality Score of 5.1/10 and Value-Trap risk of 0/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Permian Basin Royalty Trust (PBT) in 2026?
What Is the Bull Case vs the Bear Case for Permian Basin Royalty Trust (PBT)?
| Bull case | Bear case — $4.02 target (-88.9%) |
|---|---|
| No active model projects meaningful upside for PBT at $36.11. Bulls would have to argue that qualitative factors the models cannot measure will unlock value. | According to the CirclFi Quality of Company (QOC) framework, Permian Basin Royalty Trust's score of 5.1/10 signals fundamental weaknesses that could undermine the investment thesis. |
| According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model sees the stock as overvalued with a fair value of $4.02 (-88.9%), suggesting that the market price embeds overly optimistic growth assumptions. | |
| Industry headwind: reserve depletion represents a meaningful risk for Permian Basin Royalty Trust and its Oil & Gas Midstream peers. |
How Does PBT Compare to Its Oil & Gas Midstream Peers?
Valuation data pages: SBR · RBNE · TORO · WHK · SMC · TK · LNG · AM · STNG · HESM · FLNG
Which Other Stocks Score Like PBT on Quality?
Closest companies to PBT’s Quality of Company score of 5.1/10, across all industries.
- NTRR — Neutra Corp. (QOC 5.1) · analysis
- DMAC — DiaMedica Therapeutics Inc. (QOC 5.1) · analysis
- MEHA — Functional Brands Inc. (QOC 5.1) · analysis
- VENU — Venu Holding Corporation (QOC 5.1) · analysis
- IGC — IGC Pharma, Inc. (QOC 5.1) · analysis
- TII — Titan Mining Corporation (QOC 5.1) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Oil & Gas Midstream Screens Does PBT Appear In?
So Is Permian Basin Royalty Trust (PBT) Worth Buying in 2026?
Our valuation engine sends a clear cautionary signal on Permian Basin Royalty Trust at $36.11. 2/2 models flag overvaluation, median fair value sits at $11.43 (-68.4%), and the risk-reward profile appears unfavorable. Quality at 5.1/10 adds to the concern. This is a stock where patience — or avoidance — may be the optimal strategy.
These are quantitative model outputs, not investment recommendations. Permian Basin Royalty Trust's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About PBT Stock?
Should I buy PBT stock right now?
Based on CirclFi's multi-model analysis, 0 of 2 models see upside for PBT at $36.11. No active models currently project upside, suggesting the market price may already reflect or exceed fair value. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Permian Basin Royalty Trust?
Key risks include: limited model coverage (2/13 active), reducing analytical confidence; wide model disagreement (368% spread), signaling high uncertainty; general market and sector-specific risks affecting Oil & Gas Midstream companies. Always diversify and consult a financial advisor.
How does PBT compare to its competitors?
Among Oil & Gas Midstream peers, PBT holds a Quality Score of 5.1/10. Comparable companies include SBR (QOC 5.1), RBNE (QOC 4.7), TORO (QOC 5.4). The relative ranking helps investors identify whether PBT offers better fundamental quality than alternatives in the same sector.
Is PBT a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. PBT's Quality Score of 5.1/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.
What price should I buy PBT at?
CirclFi does not provide target buy prices or price alerts. However, our 2 active models produce fair value estimates ranging from $4.02 to $18.83. At $36.11, the stock trades above all model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for PBT.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad